TAVARES LINO,Tavares Lino,REIDENBERG BRUCE E.,Reidenberg Bruce E.,SACKLER RICHARD S.,Sackler Richard S.,WRIGHT CURTIS,Wright Curtis,ALFONSO MARK A.,Alfonso Mark A.,OSHLACK BENJAMIN,Oshlack Benjamin,CA
申请号：
SI200231061
公开号：
SI2316439T1
申请日:
2002.04.30
申请国别(地区):
SI
年份:
2015
代理人:
摘要：
The present invention relates to transdermal dosage form ( Fig. 1-3 ) comprising at least one activating agent and at least one inactivating agent. The dosage form ( Fig. 1-3 ) releases the inactivating agent upon disruption of the dosage form ( Fig. 1-3 ) thereby preventing or hindering misuse of the active agent contained in the dosage form ( Fig. 1-3 ).
